Trials / Completed
CompletedNCT02732886
Betafoam Diabetes Mellitus Foot Study
A Pilot Study to Compare Efficacy of Medifoam® and Betafoam® as a New Dressing Including Povidone-iodine, in Patients With Diabetes Foot Ulcer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- Mundipharma Korea Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is to compare the efficacy and safety of Medifoam® and Betafoam®, which is a new dressing that contains povidone-iodine, in patients with diabetes foot ulcer. 70 patients (35 each arm) are targeted to be enrolled in this study. Treatment follow periods are 8weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medifoam® | Foam Dressing |
| DEVICE | Betafoam® | Foam dressing including Betadine iodine |
Timeline
- Start date
- 2016-03-29
- Primary completion
- 2017-09-29
- Completion
- 2017-09-29
- First posted
- 2016-04-11
- Last updated
- 2017-11-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02732886. Inclusion in this directory is not an endorsement.